RU2003129265A - Молочно-кислые бактерии в качестве агентов для лечения и предотвращения аллергии - Google Patents
Молочно-кислые бактерии в качестве агентов для лечения и предотвращения аллергии Download PDFInfo
- Publication number
- RU2003129265A RU2003129265A RU2003129265/13A RU2003129265A RU2003129265A RU 2003129265 A RU2003129265 A RU 2003129265A RU 2003129265/13 A RU2003129265/13 A RU 2003129265/13A RU 2003129265 A RU2003129265 A RU 2003129265A RU 2003129265 A RU2003129265 A RU 2003129265A
- Authority
- RU
- Russia
- Prior art keywords
- bacterial strain
- group
- milk
- composition according
- pharmaceutical composition
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims 4
- 230000007815 allergy Effects 0.000 title claims 3
- 241000894006 Bacteria Species 0.000 title claims 2
- 235000014655 lactic acid Nutrition 0.000 title claims 2
- 239000004310 lactic acid Substances 0.000 title claims 2
- 239000003795 chemical substances by application Substances 0.000 title 1
- 229960000448 lactic acid Drugs 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 230000001580 bacterial effect Effects 0.000 claims 8
- 206010020751 Hypersensitivity Diseases 0.000 claims 4
- 235000013305 food Nutrition 0.000 claims 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 239000000047 product Substances 0.000 claims 3
- 235000013351 cheese Nutrition 0.000 claims 2
- 239000002552 dosage form Substances 0.000 claims 2
- 235000013336 milk Nutrition 0.000 claims 2
- 239000008267 milk Substances 0.000 claims 2
- 210000004080 milk Anatomy 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 241000186000 Bifidobacterium Species 0.000 claims 1
- 241000186660 Lactobacillus Species 0.000 claims 1
- 244000199866 Lactobacillus casei Species 0.000 claims 1
- 241000186672 Lactobacillus delbrueckii subsp. bulgaricus Species 0.000 claims 1
- 241000186606 Lactobacillus gasseri Species 0.000 claims 1
- 241000186605 Lactobacillus paracasei Species 0.000 claims 1
- 241000186604 Lactobacillus reuteri Species 0.000 claims 1
- 241000194036 Lactococcus Species 0.000 claims 1
- 108091005804 Peptidases Proteins 0.000 claims 1
- 239000004365 Protease Substances 0.000 claims 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 235000013339 cereals Nutrition 0.000 claims 1
- 235000015140 cultured milk Nutrition 0.000 claims 1
- 235000013350 formula milk Nutrition 0.000 claims 1
- 235000015243 ice cream Nutrition 0.000 claims 1
- 229940039696 lactobacillus Drugs 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 235000021262 sour milk Nutrition 0.000 claims 1
- 239000006228 supernatant Substances 0.000 claims 1
- 235000013618 yogurt Nutrition 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
- C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Animal Husbandry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Physiology (AREA)
- Wood Science & Technology (AREA)
- Birds (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Claims (10)
1. Бактериальный штамм группы молочно-кислой бактерии, экспрессирующий поверхностный полипептид, который содержит пептидную последовательность, имитирующую, по меньшей мере, часть конформационного эпитопа молекулы IgE, где указанным поверхностным полипептидом является заякоренная на клеточной поверхности протеаза L. bulgaricus.
2. Бактериальный штамм по п.1, выбранный из группы Lactobacillus или группы Bifidobacterium, или группы Lactococcus, и более предпочтительно происходящий из групп L. acidofilicus, L. johnsomi, L. gasseri, L. casei, L. paracasei или L. reuteri.
3. Бактериальный штамм по любому из предыдущих пунктов, где пептидная последовательность произведена из последовательности, выбранной из SEQ ID No.1 - SEQID No.19.
4. Пищевая композиция, содержащая бактериальный штамм по любому из предыдущих пунктов или его супернатант.
5. Пищевая композиция по п.4, выбранная из группы, состоящей из молока, йогурта, творога, сыра, кисло-молочных продуктов, продуктов на основе ферментированного молока, мороженого, продуктов на основе ферментированных злаков, порошков на основе молока, детских смесей или корма для домашних животных.
6. Пищевая композиция по любому из п.4 или 5, где бактериальный штамм содержится в ней в количестве от 107 до 1012 кое на дозированную форму.
7. Фармацевтическая композиция, содержащая бактериальный штамм по любому из пп.1-3.
8. Фармацевтическая композиция по п.7, где бактериальный штамм содержится в ней в количестве от 1010 до 1012 кое на дозированную форму.
9. Применение бактериального штамма по любому из пп.1-3 для приготовления принимаемого внутрь носителя для лечения аллергии и/или предотвращения появления аллергических реакций.
10. Применение фармацевтической композиции по любому из пп.5-8 для приготовления принимаемого внутрь носителя для лечения аллергии и/или появления начала аллергических реакций.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01105138.0 | 2001-03-02 | ||
| EP01105138A EP1239032A1 (en) | 2001-03-02 | 2001-03-02 | Lactic acid bacteria as agents for treating and preventing allergy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2003129265A true RU2003129265A (ru) | 2005-04-10 |
| RU2312892C2 RU2312892C2 (ru) | 2007-12-20 |
Family
ID=8176657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2003129265/13A RU2312892C2 (ru) | 2001-03-02 | 2002-03-04 | Молочно-кислые бактерии в качестве агентов для лечения и предотвращения аллергии |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7235395B2 (ru) |
| EP (2) | EP1239032A1 (ru) |
| JP (1) | JP2004528034A (ru) |
| KR (2) | KR20080111172A (ru) |
| CN (1) | CN1505678A (ru) |
| AR (1) | AR035761A1 (ru) |
| AU (1) | AU2002256639B2 (ru) |
| BR (1) | BR0207749A (ru) |
| CA (1) | CA2438833A1 (ru) |
| IL (1) | IL157468A0 (ru) |
| MX (1) | MXPA03007881A (ru) |
| NO (1) | NO20033796L (ru) |
| NZ (1) | NZ527861A (ru) |
| PL (1) | PL367208A1 (ru) |
| RU (1) | RU2312892C2 (ru) |
| WO (1) | WO2002086102A1 (ru) |
| ZA (1) | ZA200307680B (ru) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003236156A1 (en) * | 2003-04-24 | 2005-01-04 | Shin-Jen Shiao | Pharmaceutical compositions used for immune disease treatment and improvement |
| US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
| US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
| US7955834B2 (en) | 2004-06-03 | 2011-06-07 | Biogaia Ab | Method for improved breast milk feeding to reduce the risk of allergy |
| US7862808B2 (en) * | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
| US8252314B2 (en) | 2004-09-24 | 2012-08-28 | Hill's Pet Nutrition, Inc. | Hypoallergenic composition |
| CA2599909C (en) * | 2005-03-03 | 2014-12-02 | Meiji Dairies Corporation | Immune function modulating agents |
| US20060233762A1 (en) * | 2005-04-15 | 2006-10-19 | Mcmahon Robert J | Method for treating or preventing systemic inflammation in formula-fed infants |
| US7303745B2 (en) * | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
| AU2006253007B2 (en) | 2005-05-31 | 2012-12-20 | Alimentary Health Ltd | Feline probiotic Bifidobacteria |
| CA2609617C (en) | 2005-05-31 | 2014-07-08 | The Iams Company | Feline probiotic lactobacilli |
| JP2007300849A (ja) * | 2006-05-11 | 2007-11-22 | Oji Paper Co Ltd | ペットフード |
| RU2436581C2 (ru) | 2007-02-01 | 2011-12-20 | Дзе Иамс Компани | Способ уменьшения воспаления и снижения стресса у млекопитающего |
| CN102028224B (zh) * | 2007-06-21 | 2012-12-26 | 东宇生物科技股份有限公司 | 抗过敏的乳酸菌 |
| KR100913405B1 (ko) * | 2008-03-25 | 2009-08-21 | 광주과학기술원 | Ｔｈ２－매개 면역 질환의 예방 또는 치료용 조성물 |
| EP2281871B1 (en) * | 2008-04-25 | 2013-02-13 | Kameda Seika Co., Ltd. | Novel lactic acid bacterium having anti-allergic activity, anti-allergic agent, food and pharmaceutical composition each comprising the lactic acid bacterium, and process for production of the anti-allergic agent |
| US9771199B2 (en) * | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
| US9232813B2 (en) * | 2008-07-07 | 2016-01-12 | The Iams Company | Probiotic supplement, process for making, and packaging |
| US20100055082A1 (en) * | 2008-09-04 | 2010-03-04 | Jacques Alain Bauer | Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof |
| WO2010027344A1 (en) * | 2008-09-04 | 2010-03-11 | Om Pharma | Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof |
| RU2556124C2 (ru) * | 2009-05-11 | 2015-07-10 | Нестек С.А. | Lactobacillus johnsonii La1 NСС533 (CNCM 1-1225) И ИММУННЫЕ НАРУШЕНИЯ |
| US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
| PT2467031E (pt) * | 2009-08-18 | 2014-10-30 | Nestec Sa | Composição nutricional compreendendo estirpes lactococcus e redução de sintomas de alergia, especialmente em bebés e crianças |
| BR112013000649A2 (pt) | 2010-07-09 | 2016-05-31 | Sumitomo Chemical Co | processo para a produção de óxido de olefina |
| MA41020A (fr) | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
| SG11202005863TA (en) | 2018-01-12 | 2020-07-29 | Gi Innovation Inc | Composition comprising probiotics and polypeptide having binding affinity for ige and use thereof |
| JP2025533686A (ja) | 2022-10-14 | 2025-10-08 | シーエスピー テクノロジーズ，インコーポレイティド | 感湿性製品を貯蔵及び安定させるための容器及び方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5242821A (en) | 1989-07-10 | 1993-09-07 | Valio, Finnish Co-Operative Dairies' Association | Lactococcus promoter and signal sequences for expression in bacteria |
| GB9006400D0 (en) | 1990-03-22 | 1990-05-23 | Ciba Geigy Ag | Bacterial vectors |
| US6737521B1 (en) * | 1990-05-11 | 2004-05-18 | The Rockefeller University | Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
| AU652920B2 (en) | 1990-08-30 | 1994-09-15 | Valio Ltd. | Promoter probe vectors, able to replicate in E.coli, B.subtilis, lactococci and lactobacillus as well as uses thereof |
| GB9125695D0 (en) | 1991-12-03 | 1992-01-29 | Mastavac Limited | Medical preparations |
| GB9400650D0 (en) * | 1994-01-14 | 1994-03-09 | Smithkline Beecham Biolog | Expression of surface lazer proteins |
| WO1996032486A1 (en) | 1995-04-11 | 1996-10-17 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Method for the construction of vectors for lactic acid bacteria like lactobacillus such that the bacteria can efficiently express, secrete and display proteins at the surface |
| GB9518323D0 (en) | 1995-09-07 | 1995-11-08 | Steidler Lothar | Materials and methods relating to the attachment and display of substances on cell surfaces |
| US6610297B1 (en) * | 1996-03-01 | 2003-08-26 | Novartis Ag | Peptide immunogens for vaccination against and treatment of allergy |
| JPH09234078A (ja) | 1996-03-04 | 1997-09-09 | Meiji Milk Prod Co Ltd | 乳酸菌用分泌ベクター及び該ベクターを用いたタンパク質の製造方法 |
| WO1998010079A1 (en) | 1996-09-06 | 1998-03-12 | Bioteknologisk Institut | A lactic acid bacterial regulatable expression system |
| US6835550B1 (en) * | 1998-04-15 | 2004-12-28 | Genencor International, Inc. | Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
| US6642011B2 (en) * | 1998-04-15 | 2003-11-04 | Genencor International, Inc. | Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins |
| GB9908533D0 (en) * | 1999-04-14 | 1999-06-09 | Novartis Ag | Organic compounds |
| US7498162B2 (en) * | 2000-09-25 | 2009-03-03 | Nestec S.A. | Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions |
| NZ525394A (en) * | 2000-10-20 | 2005-12-23 | Bioneer As | Improved fermentation method for production of heterologous gene products in lactic acid bacteria |
| EP1343894A4 (en) * | 2000-11-02 | 2005-05-04 | Univ Singapore | AOPB GENE, PROTEIN, HOMOLOGISTS, FRAGMENTS AND VARIANTS THEREOF, AND THE USE THEREOF FOR PRESENTATION ON THE CELL SURFACE |
-
2001
- 2001-03-02 EP EP01105138A patent/EP1239032A1/en not_active Withdrawn
-
2002
- 2002-02-28 AR ARP020100732A patent/AR035761A1/es unknown
- 2002-03-04 AU AU2002256639A patent/AU2002256639B2/en not_active Ceased
- 2002-03-04 JP JP2002583617A patent/JP2004528034A/ja active Pending
- 2002-03-04 NZ NZ527861A patent/NZ527861A/en unknown
- 2002-03-04 BR BR0207749-3A patent/BR0207749A/pt not_active IP Right Cessation
- 2002-03-04 PL PL02367208A patent/PL367208A1/xx not_active Application Discontinuation
- 2002-03-04 CA CA002438833A patent/CA2438833A1/en not_active Abandoned
- 2002-03-04 EP EP02726131A patent/EP1370640A1/en not_active Withdrawn
- 2002-03-04 CN CNA028090942A patent/CN1505678A/zh active Pending
- 2002-03-04 RU RU2003129265/13A patent/RU2312892C2/ru not_active IP Right Cessation
- 2002-03-04 IL IL15746802A patent/IL157468A0/xx unknown
- 2002-03-04 KR KR1020087030377A patent/KR20080111172A/ko not_active Ceased
- 2002-03-04 MX MXPA03007881A patent/MXPA03007881A/es not_active Application Discontinuation
- 2002-03-04 WO PCT/EP2002/002326 patent/WO2002086102A1/en not_active Ceased
- 2002-03-04 KR KR10-2003-7011522A patent/KR20030082950A/ko not_active Ceased
-
2003
- 2003-08-26 NO NO20033796A patent/NO20033796L/no not_active Application Discontinuation
- 2003-08-29 US US10/652,502 patent/US7235395B2/en not_active Expired - Fee Related
- 2003-10-01 ZA ZA200307680A patent/ZA200307680B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA03007881A (es) | 2003-12-04 |
| NO20033796L (no) | 2003-10-31 |
| US20040265290A1 (en) | 2004-12-30 |
| EP1239032A1 (en) | 2002-09-11 |
| KR20080111172A (ko) | 2008-12-22 |
| IL157468A0 (en) | 2004-03-28 |
| AU2002256639B2 (en) | 2006-10-19 |
| NO20033796D0 (no) | 2003-08-26 |
| CA2438833A1 (en) | 2002-10-31 |
| PL367208A1 (en) | 2005-02-21 |
| EP1370640A1 (en) | 2003-12-17 |
| JP2004528034A (ja) | 2004-09-16 |
| BR0207749A (pt) | 2004-06-01 |
| KR20030082950A (ko) | 2003-10-23 |
| CN1505678A (zh) | 2004-06-16 |
| RU2312892C2 (ru) | 2007-12-20 |
| AR035761A1 (es) | 2004-07-07 |
| ZA200307680B (en) | 2005-01-13 |
| WO2002086102A1 (en) | 2002-10-31 |
| US7235395B2 (en) | 2007-06-26 |
| NZ527861A (en) | 2005-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2003129265A (ru) | Молочно-кислые бактерии в качестве агентов для лечения и предотвращения аллергии | |
| Chandan | Enhancing market value of milk by adding cultures | |
| AU779414B2 (en) | Lactobacillus strains preventing diarrhoea pathogenic bacteria | |
| Fooks et al. | Probiotics as modulators of the gut flora | |
| RU2003112013A (ru) | Молочно-кислые бактерии, снижающие склонность к проявлению аллергических реакций | |
| AU2009220403B2 (en) | Agents for promoting secretion and/or suppressing decrease of adiponectin | |
| KR101440490B1 (ko) | 비피도박테리아의 성장 및 생존도를 개선하기 위한 아라비아 검의 용도 | |
| RU2002119413A (ru) | Сомногенная активность непатогенных молочнокислых бактерий | |
| HUP0200374A2 (en) | Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses | |
| WO2009007515A1 (en) | Lactic acid bacteria having pro-inflammatory characteristics | |
| JP7249737B2 (ja) | 発酵乳の製造方法 | |
| Koutinas | Fermented dairy products | |
| US20240365804A1 (en) | Yogurt for dogs | |
| Songisepp | Evaluation of technological and functional properties of the new probiotic Lactobacillus fermentum ME-3 | |
| JP2009256312A (ja) | 免疫調節用組成物およびそれを用いた飲食品または飲食品素材 | |
| Korbekandi et al. | Evaluation of probiotic yoghurt produced by Lactobacillus paracasei ssp. tolerans | |
| JP4023791B2 (ja) | 抗菌物質産生乳酸菌およびそれを用いた機能性食品 | |
| CN115918726A (zh) | 饥饿素分泌促进剂 | |
| JP2006014654A (ja) | 抗体含有食品 | |
| Arepally et al. | Applications of Probiotics in Dairy Food Products | |
| Bissenova et al. | The main biological properties of lactic acid bacteria promising in the production of fermented milk products for prophylactic purposes | |
| EP4400578A1 (en) | Lactic acid bacterium, lactic acid bacterium starter, fermented milk, method for manufacturing fermented milk, and method for screening lactic acid bacterium | |
| Singh et al. | Probiotics in Dairy Industry | |
| TWI252736B (en) | A yogurt formula capable of inhibiting H. pylori | |
| Patel et al. | Semisolid Cultured Dairy Products: Principles and Applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20110305 |